Heart Valves market to Reach USD 15.98 Billion by 2026; Rising Prevalence of Cardiovascular Diseases Worldwide to Bolster Growth

The global Heart Valves market size is anticipated to reach USD 15.98 billion by 2026, on account of increasing popularity of minimally invasive surgeries. The cases of rheumatic fever, age-related changes, and other heart conditions may cause heart valve diseases and heart valve allows blood to flow in one direction and. A recent report by Fortune Business Insights™ presents a detailed analysis of the Heart Valves market in their report titled, “Heart Valves market Size, Share & Industry Analysis, By Product Type (Replacement (Aortic, Mitral, and Others), and Repair), By Valve Type (Tissue Valve and Mechanical Valve), By Procedure (Surgical and Transcatheter), By End User (Hospitals, and Specialty Clinics & Others), and Regional Forecast, 2019-2026.”As per this report, the market value was USD 6.58 billion in 2018 and is anticipated to exhibit a CAGR of 11.7% between 2019 and 2026.

Tendyne Device by Abbott Launched as World’s First CE Marked Device for Transcatheter Mitral Valve Implantation

Tendyne Valve launched by Abbott can prove beneficial when mitral repair is not considered a treatment option. This device uses the first of its kind therapeutic technology for the elimination of mitral regurgitation. Tendyne also helps to relief from heart failure symptoms and improves the quality of life in patients with high-surgical risks.The unique design of the valve has the ability of self-expanding when delivered into the heart through a small incision in the chest and implanted into the beating heart. A professor of cardiac surgery and M.D. at the University Hospital Bonn, Germany, Hendrik Treede says, “A post-permit study of the therapy will be co-guided by the MD. and interventional cardiologist, Clinique Pasteur Nicolas Dumonteil.” Such innovative devices are likely to aid in expansion of the market in the coming years.

To get a detailed report summary and research scope of this market, click here:

https://www.fortunebusinessinsights.com/industry-reports/prosthetic-heart-valve-market-101183

Rise in Heart Valve Leakage Cases to Promote Growth

Increasing geriatric population and their vulnerability to various heart disorders is a major factor promoting the Heart Valves market growth. In addition to this, the rise in number of heart valve replacement and repair surgeries are also adding impetus to the market. This, coupled with the advent of technology, current heart valves market trend of minimally invasive surgeries, availability of customized heart valves, and the launch of innovative products are expected to boost market in the forthcoming years. Furthermore, the increasing cases of heart valve leakage, improvement in medical infrastructure and facilities,and rising adoption of tissue valves are anticipated to create lucrative growth opportunities for the market in the long run.

On the flip side, factors such as high treatment cost, and the risk associated during and post-surgery may cause major hindrance to the overall market in the future years. Nevertheless, the increasing cases of heart issues among the obese population, and the advent of suture-less therapeutic options will help attract high Heart Valves market revenue in the coming years.

Abbott and Edwards LifeSciences to Dominate Market with Diverse Portfolio

As per the recent report, the global Heart Valves market is dominated by Abbott and Edwards LifeSciences out of which Edwards is leading the market. Factors such as the presence of diverse portfolio and rising preference for SAPIEN range of valves are responsible for this company to dominate the market. Besides this, Abbott, which recently entered the market by collaborating with St. Jude Medical Inc. now ranks second in the market competition. Other players operating in this market are focusing on attracting high Heart Valves market revenue and are engaging in merger and acquisition, contracts and agreements, and other joint ventures. The adoption of such strategies will help them gain a competitive edge in the market in the forthcoming years.

Major Industry Developments of Heart Valves market include:

• September 2019 –  A transcatheter aortic valve replacement system, Evolut PRO+ was launched by Medtronic for application in the U.S.

List of Major Heart Valves marketManufacturers include:

• CryoLife Inc.


• Medtronic


• Edwards LifeSciences Corporation


• Micro Interventional Devices, Inc.


• LivaNova PLC


• Abbott


• Other players

Further Report Findings

• North America earned a Heart Valves market share of USD 2.64 billion in 2018 and emerged dominant owing to the increasing number of valve repair and replacement processes and increasing number of obese people complaining of heart issues.


• With respect to valve type, the tissue valves segment held the dominant Heart Valves market share owing to the introduction of biprosthetic vales with features such as less requirement for anticoagulants, high strength and flexibility, and others.

Global Heart Valves market is segmented into: